Patients With LPIN1 Mutations Treated With Low Dose Hydroxychloroquine Sulfate
Condition: Lipin-1 Deficiency Intervention: Sponsor: Imagine Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 3, 2022 Category: Research Source Type: clinical trials
PaTcH Study: A Phase 2 Study of Trametinib and Hydroxychloroquine in Patients With Metastatic Refractory Pancreatic Cancer
Condition: Pancreatic Cancer Interventions: Drug: Trametinib; Drug: Hydroxychloroquine Sponsors: Cancer Trials Ireland; Novartis Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 26, 2022 Category: Research Source Type: clinical trials